See All Slides - tctmd.com

Slides

Presentation PCI Outcomes 2012

PCI in NSTEMI and STEMI: Essentials of Pharmacology

Presenter: C. Michael Gibson

March 23, 2012

Presentation Fellows 2012

Coronary Miscellany: Spasm, Bridging, Anomalous Coronaries, and More

Presenter: Michael Lim

April 20, 2012

Presentation Fellows 2012

Everolimus-Eluting Stents: Preclinical Foundation and Clinical Results

Presenter: Gregg Stone

April 21, 2012

$Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors$

Presentation Fellows 2012

Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors

Presenter: George Dangas

April 22, 2012

Presentation TVT 2012

Multidisciplinary Decision-Making and Case Selection

Presenter: Elizabeth Perpetua

June 02, 2012

Presentation TVT 2012

Cardiac Surgery

Presenter: Michael Mack

June 03, 2012

Presentation TVT 2012

A "Maximalist" Approach Is Best: TEE, General Anesthesia, and On-site Surgical Involvement

Presenter: Olaf Wendler

June 03, 2012

Presentation TVT 2012

Direct Annuloplasty in Evolution 3: ReCor

Presenter: Karl-Heinz Kuck

June 04, 2012

Presentation TVT 2012

EU Perspective on Defining the High-Risk Patient Suitable for TAVR

Presenter: Stephen Brecker

June 04, 2012

Presentation TVT 2012

Is TAVR Being Overused in "Futile" Patients? A Surgeon's Perspective

Presenter: D. Craig Miller

June 04, 2012

Advertisement

Slides

PCI in NSTEMI and STEMI: Essentials of Pharmacology

Coronary Miscellany: Spasm, Bridging, Anomalous Coronaries, and More

Everolimus-Eluting Stents: Preclinical Foundation and Clinical Results

Unfractionated, Low Molecular Weight Heparins, and Xa Inhibitors in ACS and PCI, With and Without GP IIb/IIIa Inhibitors

Multidisciplinary Decision-Making and Case Selection

Cardiac Surgery

A "Maximalist" Approach Is Best: TEE, General Anesthesia, and On-site Surgical Involvement

Direct Annuloplasty in Evolution 3: ReCor

EU Perspective on Defining the High-Risk Patient Suitable for TAVR

Is TAVR Being Overused in "Futile" Patients? A Surgeon's Perspective

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content